Purchase Order 75F40123P00226
Award Date
7/11/23
Potential Completion Date
9/24/26
Potential Value
$120K
Federal Agency
Food and Drug Administration
Awardee
Bruker Biospin Corp
Ultimate Awardee
Bruker Scientific LLC
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Bruker Biospin Corp for a preventive maintenance and repair service agreement for cryo-cooler components of Bruker BioSpin 47/40 systems. Valued at two hundred fourteen thousand one hundred eighty-five dollars, this contract supports maintenance of cryogenic cooling equipment through August 2028 without a set-aside designation. As a manufacturer of scientific instruments,...
This is a firm fixed price purchase order for a cryo-cooling unit awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and provider of specialized equipment, maintenance, and support services to U.S. federal government agencies. The unit is for a Bruker NMR spectrometer system at the FDA's National Center for Toxicological Research. The potential value of the contract is $116,955.00 and there was no...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and equipment, for the delivery of a Cryo Probe for Nuclear Magnetic Resonance (NMR) analysis. The contract has a potential value of $187,725.00 and a completion date of December 31, 2020. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for cryo-cooler servicing and preventative maintenance. The contract has a ceiling value of $76,735.93 and an ultimate completion date of August 11, 2023. Bruker Biospin Corp is a manufacturer of scientific instruments and provides specialized equipment, maintenance, and support services to U.S. federal government agencies, including the FDA,...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for $168,657.46 to provide service and maintenance for a Bruker Biospec 70/30 magnetic resonance imaging (MRI) cooler and cold head. The contract has a completion date of August 31, 2022. Bruker Biospin Corp is a manufacturer of scientific instruments and provides specialized equipment, maintenance, and support services...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, in the amount of $238,161.00. The contract is for the delivery of a cryogenically-cooled 13C direct detect probe and 3 years of preventative maintenance for an existing Bruker nuclear magnetic resonance (NMR) spectrometry system. There was no set-aside designation for this award. The original...
The Department of Health and Human Services Food and Drug Administration awarded a $879,190.00 firm fixed price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to upgrade the agency's 500 and 700 MHz nuclear magnetic resonance (NMR) spectrometers. The contract, which does not have a set-aside designation, will provide new equipment, including a new cryoprobe, backup room temperature probe, and automated sample changers, to improve the sensitivity and...
This federal contract award was issued by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for the procurement of a Quadruple Resonance Inverse (QCI) Detection Cryoprobe for high-field nuclear magnetic resonance (NMR) instrumentation. The contract, valued at $315,583.00, was awarded on a firm fixed-price basis without any set-aside designation. The award supports the FDA's 850 MHz Instrument Cryoprobe program, which focuses on advanced analytical...
The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a manufacturer of scientific instruments, a $398,050.00 firm-fixed-price purchase order contract to provide an NMR 400 console upgrade and deuterium probe. The contract was not set aside. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support services to various U.S. federal government agencies. This award supports the FDA's...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency, to Bruker Biospin Corp, a subsidiary of Bruker Corporation. The $127,490.00 firm-fixed-price contract is for the delivery of a TCI CryoProbeTM for an Avance 600 MHz spectrometer. This purchase order contract does not have a set-aside designation. Bruker Biospin Corp is a manufacturer of scientific instruments and provides specialized equipment, maintenance, and...